332 related articles for article (PubMed ID: 20835400)
21. [Lipid metabolism abnormalities in Chronic Kidney Disease].
Bianchi S; Baronti A; Cominotto R; Bigazzi R
G Ital Nefrol; 2016 Malattie Metaboliche e Rene; 33(S68):. PubMed ID: 27960010
[TBL] [Abstract][Full Text] [Related]
22. Effect of hypolipidemic drugs on lipoprotein-associated platelet activating factor acetylhydrolase. Implication for atherosclerosis.
Eisaf M; Tselepis AD
Biochem Pharmacol; 2003 Dec; 66(11):2069-73. PubMed ID: 14609731
[TBL] [Abstract][Full Text] [Related]
23. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
24. Periodontal diseases and association with atherosclerotic disease.
Herrera D; Molina A; Buhlin K; Klinge B
Periodontol 2000; 2020 Jun; 83(1):66-89. PubMed ID: 32385870
[TBL] [Abstract][Full Text] [Related]
25. Intermediate density lipoprotein levels are strong predictors of the extent of aortic atherosclerosis in the St. Thomas's Hospital rabbit strain.
Nordestgaard BG; Lewis B
Atherosclerosis; 1991 Mar; 87(1):39-46. PubMed ID: 1872923
[TBL] [Abstract][Full Text] [Related]
26. Serum lipid levels in patients with periodontal disease: A meta-analysis and meta-regression.
Nepomuceno R; Pigossi SC; Finoti LS; Orrico SRP; Cirelli JA; Barros SP; Offenbacher S; Scarel-Caminaga RM
J Clin Periodontol; 2017 Dec; 44(12):1192-1207. PubMed ID: 28782128
[TBL] [Abstract][Full Text] [Related]
27. [Establishment and analysis of chronic periodontitis and atherosclerosis model in Wistar rat].
Zhong LJ; Xu J; Zhang YM; Ni J; Zhou XH; Shi FC
Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Aug; 44(8):464-8. PubMed ID: 19961752
[TBL] [Abstract][Full Text] [Related]
28. Dental infections and cardiovascular diseases: a review.
Mattila KJ; Pussinen PJ; Paju S
J Periodontol; 2005 Nov; 76(11 Suppl):2085-8. PubMed ID: 16277580
[TBL] [Abstract][Full Text] [Related]
29. An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients.
Bermudez-Lopez M; Forne C; Amigo N; Bozic M; Arroyo D; Bretones T; Alonso N; Cambray S; Del Pino MD; Mauricio D; Gorriz JL; Fernandez E; Valdivielso JM
Expert Opin Ther Targets; 2019 Jul; 23(7):619-630. PubMed ID: 31100024
[No Abstract] [Full Text] [Related]
30. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
LaRosa JC
Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
[TBL] [Abstract][Full Text] [Related]
31. Atherogenicity of triglyceride-rich lipoproteins.
Krauss RM
Am J Cardiol; 1998 Feb; 81(4A):13B-17B. PubMed ID: 9526808
[TBL] [Abstract][Full Text] [Related]
32. Is obesity associated with healing after non-surgical periodontal therapy? A local vs. systemic evaluation.
Duzagac E; Cifcibasi E; Erdem MG; Karabey V; Kasali K; Badur S; Cintan S
J Periodontal Res; 2016 Oct; 51(5):604-12. PubMed ID: 26667347
[TBL] [Abstract][Full Text] [Related]
33. Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey.
Wahl PW; Warnick GR; Albers JJ; Hoover JJ; Walden CE; Bergelin RO; Ogilvie JT; Hazzard WR; Knopp RH
Atherosclerosis; 1981 Apr; 39(1):111-24. PubMed ID: 6941788
[TBL] [Abstract][Full Text] [Related]
34. Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man.
Cole TG; Patsch W; Kuisk I; Gonen B; Schonfeld G
J Clin Endocrinol Metab; 1983 Jun; 56(6):1108-15. PubMed ID: 6841553
[TBL] [Abstract][Full Text] [Related]
35. Association between obesity and chronic periodontitis: a cross-sectional study.
Palle AR; Reddy CM; Shankar BS; Gelli V; Sudhakar J; Reddy KK
J Contemp Dent Pract; 2013 Mar; 14(2):168-73. PubMed ID: 23811640
[TBL] [Abstract][Full Text] [Related]
36. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
Rosenblit PD
Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
[TBL] [Abstract][Full Text] [Related]
37. [Diabetic dyslipidaemia and the atherosclerosis].
Márk L; Dani G
Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
[TBL] [Abstract][Full Text] [Related]
38. Women, lipoproteins and cardiovascular disease risk.
LaRosa JC
Can J Cardiol; 1990 May; 6 Suppl B():23B-29B. PubMed ID: 2188715
[TBL] [Abstract][Full Text] [Related]
39. Salivary IgA to MAA-LDL and Oral Pathogens Are Linked to Coronary Disease.
Akhi R; Wang C; Nissinen AE; Kankaanpää J; Bloigu R; Paju S; Mäntylä P; Buhlin K; Sinisalo J; Pussinen PJ; Hörkkö S
J Dent Res; 2019 Mar; 98(3):296-303. PubMed ID: 30669938
[TBL] [Abstract][Full Text] [Related]
40. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins.
Walsh BW; Schiff I; Rosner B; Greenberg L; Ravnikar V; Sacks FM
N Engl J Med; 1991 Oct; 325(17):1196-204. PubMed ID: 1922206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
